Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-01-24 @ 9:25 PM
Study NCT ID:
NCT01462695
Status:
COMPLETED
Last Update Posted:
2015-08-27
First Post:
2011-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Childhood Cerebellar Anaplastic Astrocytoma | View |
| None | Childhood Cerebral Anaplastic Astrocytoma | View |
| None | Childhood Cerebral Astrocytoma | View |
| None | Childhood Infratentorial Ependymoma | View |
| None | Childhood Mixed Glioma | View |
| None | Childhood Oligodendroglioma | View |
| None | Childhood Supratentorial Ependymoma | View |
| None | Recurrent Childhood Cerebellar Astrocytoma | View |
| None | Recurrent Childhood Cerebral Astrocytoma | View |
| None | Recurrent Childhood Ependymoma | View |
| None | Recurrent Childhood Subependymal Giant Cell Astrocytoma | View |
Keywords: